Contact | Careers

New York headquarters

Ludwig Institute for Cancer Research
666 Third Avenue, 28th floor
New York, N.Y. 10017 USA
T: (212) 450 1500
F: (212) 450 1565
 

Zurich office

Ludwig Institute for Cancer Research
Stadelhoferstrasse 22
8001 Zurich, Switzerland
T: (41) (0) 44 267 62 62
F: (41) (0) 44 267 62 00

Brussels Branch

Ludwig Institute for Cancer Research
Avenue Hippocrate 74, Bte B1.74.03
Brussels BRU, 1200
T (32) 2 764 74 59
F (32) 2 762 94 05

Harvard Center

Ludwig Center at Harvard
450 Brookline Avenue
Boston MA, 02215
T 617 632 3985
F 617 632 3408

Johns Hopkins Center

Ludwig Center at Johns Hopkins
1650 Orleans Street, Cancer Research Building, Room 590
Baltimore MD, 21287
T 410 955 8878
F 410 955 0548

Lausanne Branch

Ludwig Institute for Cancer Research
Chemin des Boveresses 155
Épalinges VD, 1066
T (41) 21 314 06 24
F (41) 21 692 59 95
Careers
Pre-Clinical Research Associate

Pre-Clinical Research Associate

Ludwig Cancer Research is an international collaborative network of acclaimed scientists that has pioneered cancer research and landmark discovery for more than 40 years. Ludwig combines basic science with the ability to translate its discoveries and conduct clinical trials to accelerate the development of new cancer diagnostics and therapies. Since 1971, Ludwig has invested nearly $2.7 billion in life-changing science through the not-for-profit Ludwig Institute for Cancer Research and the six U.S.-based Ludwig Centers.

Scientists at the Lausanne Branch focus on tumor immunology and immunotherapy. This includes the mechanisms by which tumors thwart immune attack and the development of novel immunotherapies, especially those in which the treatment is tailored to a patient’s cancer—such as dendritic cell vaccines and therapies that involve the manipulation and reinfusion of a patient’s T cells.
 


The laboratory of Dr. George Coukos at Ludwig Lausanne comprises an international group of highly motivated research associates, post-doctoral fellows, students and technicians. The T-cell engineering team focuses heavily on the development of clinically translatable immunotherapy-based projects, with strong emphasis on protocol development and optimization. There is an on-site GMP facility under construction in Epalinges and a variety of clinical trials under the direction of Dr. Coukos are underway and planned at the CHUV. Thus, this post offers the opportunity to work on exciting projects that have the potential to be translated to the clinic and have an important impact on cancer patients.

The HI-TIDE T-cell engineering team of Dr. Melita Irving in the Coukos laboratory is seeking a Pre-Clinical Research Associate. The position will start as a 1-year contract beginning November 1, 2017, however, candidates interested in a long-term commitment are also encouraged to apply.

The Associate will evaluate various combinatorial cancer immunotherapies (CAR/TCR T-cell transfer, check-point blockade, radiotherapy, chemotherapy, etc.) that have been developed by the team and are of strong interest for clinical translation. The position will involve the screening of novel compounds, but will not include an independent research program. The candidate will work closely with the project leader, post-docs and PhD students, to ensure robust and reproducible in vivo testing. A small group of technicians will provide further support. The candidate will help co-ordinate mice in PyRAT and take a leadership role in writing various reports and authorizations for the lab pertaining to in vivo work.

Tumor models include both syngeneic ones like B16 melanoma in C57BL/6 mice, and human tumors/cell lines engrafted in NSG mice. Tumor control by imaging and/or caliper measurement, tumor microenvironment evaluation pre- and post-treatment, and immune response to therapy will be characterized. Blood, lymph node, tumor and organ extractions will be made. Frequently used in vitro methods will include primary T-cell culture (both human and mouse), microscopy, multi-colour flow cytometry for T-cell phenotyping etc., pPCR etc.

The ideal candidate will possess the following qualifications:

  • PhD or post-doctoral experience in cancer research and immunology.
  • Expertise in T-cell biology and tumor immuno-biology.
  • Extensive hands-on experience with pre-clinical in vivo tumor models and cancer immunotherapy.
  • LTK1 training or equivalent for working with animals in Switzerland. LTK2 certification also desirable but training can be completed upon hiring.
  • Background in T-cell engineering desirable but not required.
  • Strongly motivated, good communication skills and team spirit.
  • Attention to detail, capable of trouble-shooting, working under pressure and meeting deadlines.
  • Fluent spoken and written English is required.

Interested candidates should send a CV, a letter of motivation and contact information for 2-3 references to Melita.Irving@unil.ch.

M.I.T. Center

Ludwig Center at MIT
77 Massachusetts Avenue, 76-158
Cambridge MA, 02139
T 617 258 5159
F 617 258 5213

MSK center

Ludwig Center at MSK
1275 York Avenue, Box 212
New York NY, 10065
T 646 888 3165
F 646 422 0453

N.Y. Collaborative Laboratory

Ludwig Collaborative Laboratory
MSK, 417 E. 68th Street, Z1525
New York NY, 10065
T 646 888 2315

Oxford Branch

Ludwig Institute for Cancer Research
University of Oxford, Nuffield Department of Clinical Medicine
Old Road Campus Research Building, Headington OXF, OX3 7DQ
T +44 (0)1865 617500
F + 44 (0) 1865 617515
Careers
Clinical Research Fellow (GI)

Clinical Research Fellow (GI)

Ludwig Cancer Research is an international collaborative network of acclaimed scientists that has pioneered cancer research and landmark discovery for more than 40 years. Ludwig combines basic science with the ability to translate its discoveries and conduct clinical trials to accelerate the development of new cancer diagnostics and therapies. Since 1971, Ludwig has invested nearly $2.7 billion in life-changing science through the not-for-profit Ludwig Institute for Cancer Research and the six U.S.-based Ludwig Centers.

Scientists at the Oxford Branch of the Ludwig Institute for Cancer Research focus on a variety of subjects of importance to cancer research. These range from intracellular signaling, genomics and epigenetics to tumor immunology, oxygen sensing and angiogenesis. With stable core funding from Ludwig Cancer Research and access to state-of-the-art facilities in the renowned academic environment of the University of Oxford at the Old Road Research Campus, our PIs have both the opportunity and means to pursue groundbreaking basic and translational scientific research.


Clinical Research Fellow (GI)

Nuffield Department of Medicine (NDM), Ludwig Institute for Cancer Research, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford, UK

Grade E64: £31,931 - £51,176 p.a.

Only online applications received by 12.00 noon (UK time) on 17 January 2018 will be considered.

The online application is available here.

Ludwig Oxford is seeking a Clinical Research Fellow with excellent communication skills to join the research group led by Professor Xin Lu and work in collaboration with Professor Mark Middleton, Department of Oncology, Oxford.

We expect our research program will contribute significantly to improving the diagnosis, treatment and survival of patients with gastrointestinal (GI) cancers. As a Clinical Research Fellow with our group, you will therefore be expected to have a special interest in such malignancies and in exploring the molecular mechanisms that drive their genesis and shape their responses to therapy, particularly immunotherapy.

To qualify, applicants must possess a medical degree with GI surgical, oncological or pathology experience and be registered with the General Medical Council (UK). Excellent IT skills—including email and word processing as well as the use of spreadsheets and databases—are essential.

To apply for this position, please upload to the Oxford University jobs page (http://bit.ly/2yXlOSm) a CV and supporting statement that explains how you meet the selection criteria for this post.

Group Leader in Cancer Big Data

Group Leader in Cancer Big Data

Ludwig Cancer Research is an international collaborative network of acclaimed scientists that has pioneered cancer research and landmark discovery for more than 40 years. Ludwig combines basic science with the ability to translate its discoveries and conduct clinical trials to accelerate the development of new cancer diagnostics and therapies. Since 1971, Ludwig has invested nearly $2.7 billion in life-changing science through the not-for-profit Ludwig Institute for Cancer Research and the six U.S.-based Ludwig Centers.

Scientists at the Oxford Branch of the Ludwig Institute for Cancer Research focus on a variety of subjects of importance to cancer research. These range from intracellular signaling, genomics and epigenetics to tumor immunology, oxygen sensing and angiogenesis. With stable core funding from Ludwig Cancer Research and access to state-of-the-art facilities in the renowned academic environment of the University of Oxford at the Old Road Research Campus, our PIs have both the opportunity and means to pursue groundbreaking basic and translational scientific research.
 


Group Leader in Cancer Big Data

Nuffield Department of Medicine (NDM), Ludwig Institute for Cancer Research, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford, UK

Grade 9: £46,336 - £53,691 with a discretionary market supplement up to £64,000 p.a.

Only online applications received by 12.00 noon (UK time) on 17 January 2018 will be considered.

The online application is available here

Ludwig Oxford is looking for a Group Leader with research interests in statistical and computational analysis and integration of genome-scale data to build a research program relating to cancer biology. Qualified applicants will have a Ph.D. level or equivalent degree in a quantitative science with research experience in academia or industry.

As Group Leader, you will have excellent communication skills and a proven ability to deliver high-quality novel research, for example through journal publications, patents and other IP or authorship of widely-used software.

You will have a background in a quantitative discipline, such as mathematics, statistics, engineering or computer science, and experience in the analysis of high-dimensional data. Knowledge of cancer genomics, proteomics, imaging or other high-throughput biomedical data would be an advantage, but we also encourage applications from individuals from different research domains or non-academic backgrounds who are interested in applying their skills to new challenges.

With mentorship from senior group leaders within Ludwig Oxford and the Big Data Institute (BDI), Oxford, you will develop a productive research group, supervise postgraduate researchers and graduate students and collaborate with other members of the BDI, Ludwig Oxford and the wider Oxford community. An understanding of how to lead a successful research programme and develop new avenues of research is therefore important. In addition to your salary, funds will be available to establish a small research group.

To apply for this post, you must upload, by the deadline noted above, a CV and supporting statement which explains how you meet the selection criteria for the post.

To apply for this position, please upload to the Oxford University jobs page (http://bit.ly/2qKyP33) a CV and supporting statement that explains how you meet the selection criteria for this post.

 

Group Leaders I

Group Leaders I

Ludwig Cancer Research is an international collaborative network of acclaimed scientists that has pioneered cancer research and landmark discovery for more than 40 years. Ludwig combines basic science with the ability to translate its discoveries and conduct clinical trials to accelerate the development of new cancer diagnostics and therapies. Since 1971, Ludwig has invested nearly $2.7 billion in life-changing science through the not-for-profit Ludwig Institute for Cancer Research and the six U.S.-based Ludwig Centers.

Scientists at the Oxford Branch of the Ludwig Institute for Cancer Research focus on a range of subjects of importance to cancer research. These range from intracellular signaling, genomics and epigenetics to tumor immunology, oxygen sensing and angiogenesis. With stable core funding from Ludwig Cancer Research and access to state-of-the-art facilities in the renowned academic environment of the University of Oxford at the Old Road Research Campus, our PIs have both the opportunity and means to pursue groundbreaking basic and translational scientific research.

Group Leader in Infection, Immunity and Tumour Immunology

Nuffield Department of Medicine (NDM), Ludwig Institute for Cancer Research, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford, UK

Only online applications received by 12:00 noon (UK time) on 25 January 2018 will be considered

The online application is available here

Grade 9: £46,336 - £53,691 with a discretionary range to £58,655 p.a.

Ludwig Oxford is looking for a Group Leader with research interests in infection, immunity or tumour immunology to build a research programme relating to cancer biology. Applicants must hold a relevant Ph.D/D.Phil qualification and possess significant post-qualification research experience.

As a Group Leader, you will develop an effective, productive research group, supervise postgraduate researchers and graduate students and form constructive collaborations. You will receive mentorship from senior group leaders within the Ludwig Institute and the wider Oxford community. In addition to your salary, funds will be available to establish a small research group.

You will need have sufficient specialist knowledge in inflammation and/or immunology to develop research programmes and methodologies. As Group Leader, you will also be required to have excellent written and oral communication skills, with the ability to present to the scientific community and the lay public.

To apply for this position you are required to upload, by the deadline noted above, a future research proposal, a CV and a supporting statement that explains how you meet the selection criteria for the post.

Group Leaders II

Group Leaders II

Ludwig Cancer Research is an international collaborative network of acclaimed scientists that has pioneered cancer research and landmark discovery for more than 40 years. Ludwig combines basic science with the ability to translate its discoveries and conduct clinical trials to accelerate the development of new cancer diagnostics and therapies. Since 1971, Ludwig has invested nearly $2.7 billion in life-changing science through the not-for-profit Ludwig Institute for Cancer Research and the six U.S.-based Ludwig Centers.

Scientists at the Oxford Branch of the Ludwig Institute for Cancer Research focus on a range of subjects of importance to cancer research. These range from intracellular signaling, genomics and epigenetics to tumor immunology, oxygen sensing and angiogenesis. With stable core funding from Ludwig Cancer Research and access to state-of-the-art facilities in the renowned academic environment of the University of Oxford at the Old Road Research Campus, our PIs have both the opportunity and means to pursue groundbreaking basic and translational scientific research.

Group Leader in Infection, Immunity and Tumour Immunology

Nuffield Department of Medicine (NDM), Ludwig Institute for Cancer Research, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford, UK

Grade 10: £53,691 - £62,219 with a discretionary range to £67,972 p.a.

Only online applications received by 12:00 noon (UK time) on 25 January 2018 will be considered

The online application is available here.

Ludwig Oxford is recruiting a Group Leader with research interests in infection, immunity or tumour immunology to head a research group focusing on cancer biology. Applicants must hold a relevant Ph.D/D.Phil qualification and possess significant post-qualification research experience.

As Group Leader, you will have primary responsibility for the development, management and strategic direction of a significant research group with substantial resources from core and external funding. As a recognised authority in your field, you will have an established international reputation that you will use to create effective collaborations for the benefit of the research group and the Ludwig Institute. In addition to managing a research group, you will be expected to contribute to the overarching vision and strategic direction of the Oxford Branch of the Ludwig Institute.[UK1] 

You will have experience in leading successful and original research programmes, managing research staff and supervising Ph.D students. Further, you will have a specialist’s expertise and an international reputation in the fields of infection, immunity or tumour immunology, and a track record of attracting funding and managing budgets efficiently.

To apply for this position you are required to upload, by the deadline noted above, a future research proposal, a CV and a supporting statement that explains how you meet the selection criteria for the post.

 

Postdoctoral Research Scientist—Tumour Suppression

Postdoctoral Research Scientist—Tumour Suppression

Ludwig Cancer Research is an international collaborative network of acclaimed scientists that has pioneered cancer research and landmark discovery for more than 40 years. Ludwig combines basic science with the ability to translate its discoveries and conduct clinical trials to accelerate the development of new cancer diagnostics and therapies. Since 1971, Ludwig has invested nearly $2.7 billion in life-changing science through the not-for-profit Ludwig Institute for Cancer Research and the six U.S.-based Ludwig Centers.

Scientists at the Oxford Branch of the Ludwig Institute for Cancer Research focus on a variety of subjects of importance to cancer research. These range from intracellular signaling, genomics and epigenetics to tumor immunology, oxygen sensing and angiogenesis. With stable, core funding from Ludwig Cancer Research and access to state-of-the-art facilities in the renowned academic environment of the University of Oxford at the Old Road Research Campus, our PIs have both the opportunity and means to pursue groundbreaking basic and translational scientific research.


Postdoctoral Research Scientist—Tumour Suppression

Nuffield Department of Medicine (NDM), Ludwig Institute for Cancer Research, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford, UK

Grade 7: £31,604 - £38,833 p.a.

Only online applications received by 12:00 noon (UK time) on 17 January 2018 will be considered.

The online application is available here.

Ludwig Oxford seeks a motivated Postdoctoral Research Scientist to work on the target selectivity of p53, the sequence-specific transcription factor with a plethora of genomic targets. Reporting to Professor Xin Lu, the postdoc will use a wide range of molecular and cellular biology techniques, including confocal microscopy, to explore the molecular mechanisms of tumour suppression.

The ultimate aim of this research is to develop new strategies for the diagnosis and treatment of cancer. As a Postdoctoral Research Scientist, the researcher will be expected to provide guidance to less experienced members of the research group, such as Ph.D and project students. A detailed knowledge of tumour suppressors and transcription factor selectivity would therefore be desirable.

The successful applicant will hold a Ph.D/D.Phil (or be near completion) and have a first author publication record in an international peer-reviewed journal. Applicants must also demonstrate the capacity to manage their own academic research and associated activities, and possess excellent communication skills.

To apply for this position, please upload to the Oxford University jobs page (http://bit.ly/2BJBtdp) a CV and supporting statement that explains how you meet the selection criteria for this post.

San Diego Branch

Ludwig Institute for Cancer Research
9500 Gilman Drive, Cellular and Molecular Medicine East Building
La Jolla CA, 92093-0670
T 858 534 7802
F 858 534 7750

Stanford Center

Ludwig Center at Stanford
Lokey Stem Cell Research Building - 265 Campus Dr, 3rd Floor
Stanford CA, 94305-5323
T 650 234 0675

Stockholm Branch

Ludwig Institute for Cancer Research
Karolinska Institute, Box 240
Stockholm ST, SE-17177
T (46) 8 524 871 00
F (46) 8 33 28 12

University of Chicago Center

Ludwig Center at the University of Chicago
5758 South Maryland Avenue MC 9006
Chicago IL, 60637
T 773 702 0817
F 773 834 7233